A5007944145- Colorectal Cancer Treatments and Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Gastrointestinal disorders and treatments
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Lung Cancer Diagnosis and Treatment
- Intestinal Malrotation and Obstruction Disorders
- Esophageal Cancer Research and Treatment
- Child Nutrition and Feeding Issues
- Radiomics and Machine Learning in Medical Imaging
- Gastric Cancer Management and Outcomes
- Colorectal and Anal Carcinomas
- Congenital gastrointestinal and neural anomalies
- Cancer Diagnosis and Treatment
- Esophageal and GI Pathology
- Bariatric Surgery and Outcomes
Centre Hospitalier Universitaire de La Réunion
2019
Université de Toulouse
2019
Hôpital Rangueil
2018-2019
Hôpital Larrey
2016
Hôpital des Enfants
2014
BACKGROUNDColorectal cancer is the third most common in men and second women worldwide.Almost a of patients has or will develop liver metastases.Neoadjuvant chemotherapy (NAC) recently become nearly systematic prior to surgery colorectal livers metastases (CRLMs).The response NAC evaluated by radiological imaging according morphological criteria.More recently, been based on histological criteria resected specimen.The often used score tumor regression grade (TRG), which considers necrosis,...